Prenatal and Newborn Genetic Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Prenatal and New-born Genetic Testing Market size was valued over USD 3.4 billion in 2017 and is expected to witness more than 11% CAGR from 2021 to 2025.

Babies who look healthy at birth and are born into healthy homes are likely to have serious medical conditions, including genetic disorders such as phenylketonuria (PKU), cystic fibrosis, Down syndrome, and sickle cell disease. Prenatal and neonatal genetic tests are performed as a means of early diagnosis and determine if the baby is at risk of developing certain disorders due to hereditary disorders. Screening and diagnostic tests provide information about the health of you and your baby, so they are meant to make the best health care decisions before and after your baby is born. These tests treat the genetic disorders identified in most babies at birth early, helping them grow healthy to enjoy a productive life.

Market Segments

By Product

• Diagnostic
• Screening

By Disease Indication

• Cystic Fibrosis
• Sickle Cell Anemia
• Down Syndrome
• Phenyketonuria
• Other Diseases

By End User

• Hospitals & Clinics
• Diagnostic Centres
• Other End Users

Key Players

Some of the leading players include Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America, Natera, Qiagen, Sequenom, Trivitron Healthcare and Verinata health.

Scope of the Report

The research study analyzes the global Prenatal and Newborn Genetic Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Prenatal and Newborn Genetic Testing Market Report

1. What was the Prenatal and Newborn Genetic Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027). 2. What will be the CAGR of the Prenatal and Newborn Genetic Testing Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Prenatal and Newborn Genetic Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.